Case ReportJournal of Pharmacology and PharmacotherapeuticsVol. 2 | Issue 3 | 2011 | pp. 185–6Open access
Deep vein thrombosis in a woman taking oral combined contraceptive pills
- 1*,
- 1
- 1 Department of Pharmacology, P.D.U. Medical College, Rajkot, Gujarat, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Kiran G. Piparva
Department of Pharmacology, P.D.U. Medical College, Rajkot, Gujarat, India.
Email: kiranpiparva@yahoo.co.in
Copyright: © 2011 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2011
How to cite
Piparva, K. G., & Buch, J. G. (2011). Deep vein thrombosis in a woman taking oral combined contraceptive pills. Journal of Pharmacology and Pharmacotherapeutics, 2(3), 185–6. https://doi.org/10.4103/0976-500X.83284
Abstract
Oral combined contraceptive pill (OCCP) is popular as birth control pills. Like all other drugs, they are not free from risks. Women taking certain types of OCCP have higher risk of developing deep vein thrombosis (DVT). A 29 year old married woman had taken OCCP for 3.5 months, developed deep vein thrombosis of left leg. Hereditary and acquired causes of DVT were excluded. She was treated with parenteral and oral anticoagulants simultaneously and was advised to discontinue OCCP. Initially the risk of blood clot was believed to be due to dose of estrogen but recent study relates it to the type of progesterone involved in OCCP. Thus, it is still a matter of debate, whether to associate risk of DVT to the amount of estrogen alone or also to the type of progestin. Apart from careful selection of patients, one should also look for the risk of venous thromboembolism irrespective of type of OCCP prescribed.
Keywords
Subject
Article metadata
| Title | Deep vein thrombosis in a woman taking oral combined contraceptive pills |
|---|---|
| Authors | Kiran G. Piparva; Jatin G. Buch |
| Affiliations | Department of Pharmacology, P.D.U. Medical College, Rajkot, Gujarat, India. |
| Corresponding author | kiranpiparva@yahoo.co.in |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 2, Issue 3 (2011) |
Also in this issue
- Fingolimod (Gileyna, FTY720): Innovative treatment for multiple sclerosispp. 207–208
- Drugs on Saturday to combat “Prescription drug abuse”pp. 217–218
- A tale of too many strengths: Can we minimize prescribing errors and dispensing errors with so many formulations in the market?pp. 147–149
- Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safetypp. 150–157
- Antibiotic sensitivity profile of bacterial pathogens in postoperative wound infections at a tertiary care hospital in Gujarat, Indiapp. 158–164
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026